SCHEMBL6664950

SCHEMBL6664950

CCOC(=O)c1cnn(CO)c1C

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.56
KMT2A Q03164 3/20 0.56
NPC1 O15118 4/20 0.51
LMNA P02545 3/20 0.51
RAB9A P51151 4/20 0.48
MAPT P10636 2/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 6/20 0.47
HPGD P15428 2/20 0.47
POLB P06746 1/20 0.46
TSHR P16473 3/20 0.46
MEN1 O00255 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13462878 0.88 SMN1; SMN2 (0.58) SMN1; SMN2KMT2ANPC1LMNARAB9A
SCHEMBL3509334 0.87 SMN1; SMN2 (0.54) SMN1; SMN2KMT2ANPC1LMNARAB9A
SCHEMBL6154283 0.83 KMT2A (0.53) SMN1; SMN2KMT2ANPC1LMNARAB9A
SCHEMBL9312267 0.81 KMT2A (0.52) SMN1; SMN2KMT2ANPC1LMNARAB9A
SCHEMBL17438055 0.81 KMT2A (0.52) SMN1; SMN2KMT2ANPC1LMNARAB9A
SCHEMBL1302838 0.81 SMN1; SMN2 (0.52) SMN1; SMN2KMT2ANPC1LMNARAB9A
SCHEMBL3510101 0.81 SMN1; SMN2 (0.52) SMN1; SMN2KMT2ANPC1LMNARAB9A
SCHEMBL12875695 0.80 KMT2A (0.51) SMN1; SMN2KMT2ANPC1LMNARAB9A
SCHEMBL8573566 0.79 RAB9A (0.50) SMN1; SMN2KMT2ANPC1LMNARAB9A
SCHEMBL7820902 0.79 RAB9A (0.50) SMN1; SMN2KMT2ANPC1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1441725-A1 BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS Aventis Pharmaceuticals Inc. (US) 2004-08-04 EP disclosed
WO-2003035065-A1 BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS AVENTIS PHARMACEUTICALS INC (US) 2003-05-01 WO disclosed